Ceftriaxone and Jaundice in Neonates
Ceftriaxone and Jaundice in Neonates
Ceftriaxone is an antibiotic often used for the management of sepsis. Neonates commonly have
 jaundice during the first postnatal week. Ceftriaxone will be given as standard of care for
 sepsis and investigators will observe the effect on jaundice.
Inclusion Criteria:

 -  Term infants with sepsis requiring IV antibiotics for more than 3 days and who has
 total serum bilirubin 6-12 mg/dL and resolving by day 4 of life.

 Exclusion Criteria:

 -  Infants with asphyxia (Apgar score <3 at 5 minutes), chromosomal disorder, failed
 hearing test at baseline, family history of hearing loss, unconjugated
 hyperbilirubinemia requiring phototherapy, TORCH infection, craniofacial
 malformations, listeria monocytogenes infection, and any clinical conditions which
 will preclude discharge to home.